EULEXIN (Flutamide) – Prostate Cancer | HongKong DengYue Medicine

  • Generic Name/Brand Name: ​Flutamide / EULEXIN®
  • Indications: Prostate Cancer
  • Dosage Form: ​Oral capsule
  • Specification: 250 mg × 100 capsules/box

Flutamide Application Scope

EULEXIN is indicated for the treatment of prostate cancer. It can be used in combination with surgical or medical castration to block the effects of androgens, which promote tumor growth. In certain cases, it may also be used as monotherapy to manage disease progression. It functions as a non-steroidal anti-androgen, binding to androgen receptors and inhibiting the proliferation of androgen-dependent cancer cells. This therapy helps slow tumor growth, reduce symptoms, and improve patient outcomes in advanced or metastatic prostate cancer.

eulexin flutamide
eulexin flutamide

Flutamide Characteristics

  • Ingredients: Flutamide

  • Properties:​ Non-steroidal anti-androgen, inhibits androgen receptor signaling

  • Packaging Specification:​ 250 mg × 100 capsules/box

  • Storage:​ Store at 20–25°C, protect from moisture and light

  • Expiry Date: As indicated on the package

  • Executive Standard: FDA approved

  • Approval Number: NDA 018825

  • Date of Revision: January 2024

  • Manufacturer: Schering Corporation

Guidelines for the Use of EULEXIN

  • Dosage and Administration:

    • Recommended Dose: 250 mg orally three times daily

    • Administration: Take with water, can be taken with or without food

    • Missed Dose: Take as soon as possible on the same day; do not double the next dose​

  • Adverse Reactions:

    • Common Adverse Reactions (≥5%):

      • Hot flashes, nausea, diarrhea, liver enzyme elevation, gynecomastia, fatigue

    • Serious Adverse Reactions:

      • Hepatotoxicity, severe gastrointestinal symptoms, hematologic effects​

  • Contraindications: History of severe hypersensitivity to eulexin or any excipients

  • Precautions:

    • Liver Function: Monitor liver enzymes regularly

    • Pregnancy and Lactation: Contraindicated in women; advise male patients on contraception

Flutamide Interactions

  • CYP1A2 Substrates: Monitor for increased toxicity

  • Other Androgen Deprivation Therapies: Combined effects may require monitoring

 

Note:

  • If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
  •  This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.
Contact Us
Contact Form Demo